Correlation between albuminuria and interstitial injury marker reductions associated with SGLT2 inhibitor treatment in diabetic patients with renal dysfunction

Abstract Background We investigated the effects of sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration focusing on its involvement in tubulo-interstitial disorders in diabetic kidney. Methods Enrolled patients with diabetic kidney disease received a mean dose of 52.3 mg of an SGLT2i (ip...

Full description

Bibliographic Details
Main Authors: Saeko Sato, Kaori Takayanagi, Taisuke Shimizu, Koichi Kanozawa, Takatsugu Iwashita, Hajime Hasegawa
Format: Article
Language:English
Published: BMC 2022-08-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-022-00737-5

Similar Items